It already did its pull pull back from around 83-84 to 81. . This will not go back to 81 unless there is a 500 point market drop and even then, it is unlikely.
Dilution was already accounted for.
Very low float and very few shares
Huge amount of cash
Major breakthrough drug
Unlikely to retreat much and will likely continue to run
You could short against the box and cover if the stock retreats, while protecting yourself on the upside so you loss doesn't increase. It seems to pull back fro time to time, but the pull backs are becoming smaller and smaller..
It was the market maker's balance that likely included a trade because of the unusual size. It was not a buy. It was a sell at the bid: 37.41 Anyone with time and sales archive and does not suffer from color blindness can see this.
I wonder if Trump feels as good as you do when you insult someone. Perhaps it is just the thing dopes do. If you didn't comprehend the meaning of my post, then you need more than reading lessons. Thi not an 8 billion dollar company.
It is hard to determine just what is going on because there are so few free shares to drive the price up dramatically. I doubt they are close to any offer. If they were, there wouldn't be so many hedged shares. Until ADP, there isn't anything unknown about this company at this time. If they come up short on prescriptions, the stock could fall and we all know how quickly ACAD can fall. I don't think anything will move this stock before there is an ADP indication. It can't even hold above 37, which is where it was before the article. The article will have little effect on the price. Those who bought above 37 AH on Friday will bail if they can get their money back, having realized their mistake. I will be pleasantly surprised if it closes above 37.
They have made so much shorting against the box (50 to 17) that if it costs them a few bucks to get out of their shorts, it is no big deal. The Baker Brothers, for instance, are probably already locked in to at least a billion in profit.
You can bet your bottom dollar that the institutions have been shorting against the box. There aren't 22 million shares outside of their holdings. If ACAD is engaged in fielding serious buyout inquiries, yes, I am sure that the institutions know about them. That article was about as vague as it could be. Of course it is possible that a drug company made an inquiry about what price the Baker Brothers and Fidelity (which owns as much as the BB's) would entertain, but that is a far cry from an offer.
Why, buy under 45 when you can likely buy it under 36 today? It's only 36.31 at 5:45 EST. It is nothing but speculation. Institutions are clearly hedging with shorts against the box. From where else could 22 million short shares come? Don't you think institutions would know if a sale were near? Who do you think is the selling the company, the CEO? Do you think the Baker Brothers just told him to text them when a deal is found and done?.This is pure gossip. The blurb doesn't even bother to quote an "anonymous" source of "someone close to the situation." Calm down. Nothing will will happen before the end of the year or next.
nothing more. Remember when the stock ran to 50 because ACAD cancelled upcoming presentations and everyone thought it was because of a sale? Of course, if anyone stopped to think about it, why would an acquiring company want to interfere with a presentation. The problem with web based news outlets is that they have to fill space and there isn't enough factual news in the world to fill space so they speculate. ACAD isn't Genentech.
Never ask a dairy farmer how many cows he owns. It is as rude as asking to see his bank account.